COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Edenred - Disclosure of Share Capital and Voting Rights as of December 31, 2023
This press release discloses the share capital and voting rights of Edenred as of December 31, 2023, in accordance with the French Commercial Code and the General Regulations of the Autorité des marchés financiers. The total shares outstanding, potential voting rights, and exercisable voting rights are provided, excluding rights attached to shares held in treasury. More information can be found on edenred.com, Investors/Shareholders section then Regulated Information. -
COMMUNIQUÉ RÉGLEMENTÉ
Edenred - Déclaration du nombre d'actions et de droits de vote au 31 décembre 2023
Edenred déclare le nombre d'actions et de droits de vote conformément à la réglementation en vigueur. Toute l’information est disponible sur le site web edenred.com, rubrique Investisseurs / Actionnaires -
COMMUNIQUÉ RÉGLEMENTÉ
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/12/2023
Déclaration de répartition de capital et droits de vote pour LNA Santé au 31/12/2023 par Société Générale conformément à l'article 223-16 du règlement général de l'Autorité des Marchés Financiers -
-
COMMUNIQUÉ DE PRESSE
Canadian Overseas Petroleum Ltd Announces Conversion of Bond Payments
Canadian Overseas Petroleum Limited announces the issuance of 305,598,679 common shares for the settlement of Conversion Payment amounts. The Company now has a total of 1,344,370,498 common shares issued and outstanding. Shareholders may use this figure for the necessary calculations under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The Common Shares will be admitted to the FCA's Official List and to trading on the London Stock Exchange's main market for listed securities within the next twelve months. For further information, please refer to the contact details provided in the press release. -
COMMUNIQUÉ DE PRESSE
Biophytis annonce la publication des résultats de son étude de phase 2-3 COVA dans eClinicalMedicine, partie de The Lancet
Biophytis annonce la publication des résultats de son étude de phase 2-3 COVA dans eClinicalMedicine, partie de The Lancet. Biophytis, société de biotechnologie, annonce des résultats prometteurs pour le traitement des symptômes respiratoires des formes sévères de COVID-19 -
COMMUNIQUÉ DE PRESSE
Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet
Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet. The publication highlights the positive results of Sarconeos (BIO101) in reducing the risk of death or respiratory failure in adults hospitalized with severe respiratory symptoms due to COVID-19. Biophytis will also host press conferences to discuss the potential and clinical benefits of Sarconeos (BIO101) in severe forms of COVID-19 and its exploration in the treatment of other respiratory viral infections. For more information, visit www.biophytis.com -
COMMUNIQUÉ DE PRESSE
Runway Influence: Harnessing The Power of Model Influencers for Unparalleled Brand Success
Runway Influence, a leading influencer marketing agency in Los Angeles, specializes in collaborating with high-profile models, celebrities, and renowned brands. Their unique niche in working exclusively with a network of model influencers offers a sophisticated and credible approach to brand endorsements. The agency's visionary leadership, commitment to innovation, and diverse clientele enable them to create impactful influencer campaigns for global brands. Their recognition in prestigious publications underscores their expertise and prominence in the dynamic world of digital marketing and influencer engagement. -
COMMUNIQUÉ DE PRESSE
Redishred Capital Corp. Announces the Acquisition of MDK Recycling LLC
Redishred Capital Corp announces the successful completion of its acquisition of MDK Recycling LLC, a Michigan-based company offering paper and hard drive shredding, product destruction, paper recycling, and scanning services. The acquisition is expected to significantly contribute to Redishred's cash flows and earnings, allowing the company to expand its shredding and scanning footprint in the United States and enter the Detroit, Michigan market. The purchase price for this acquisition, including earnouts, is estimated to be between $0.5 million and $0.8 million USD, depending on the performance of MDK relative to earn-out targets. For more information about this acquisition, please visit the Redishred website or contact the company's CEO or CFO.
